AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer von Jänne, Pasi A, Yang, James Chih-Hsin, Kim, Dong-Wan, Planchard, David, Ohe, Yuichiro, Ramalingam, Suresh S, Ahn, Myung-Ju, Kim, Sang-We, Su, Wu-Chou, Horn, Leora, Haggstrom, Daniel, Felip, Enriqueta, Kim, Joo-Hang, Frewer, Paul, Cantarini, Mireille, Brown, Kathryn H, Dickinson, Paul A, Ghiorghiu, Serban, Ranson, Malcolm

Volltext

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial von Herbst, Roy S, Prof, Baas, Paul, Prof, Kim, Dong-Wan, MD, Felip, Enriqueta, MD, Pérez-Gracia, José L, MD, Han, Ji-Youn, Prof, Molina, Julian, MD, Kim, Joo-Hang, Prof, Arvis, Catherine Dubos, MD, Ahn, Myung-Ju, Prof, Majem, Margarita, MD, Fidler, Mary J, MD, de Castro, Gilberto, MD, Garrido, Marcelo, MD, Lubiniecki, Gregory M, MD, Shentu, Yue, PhD, Im, Ellie, MD, Dolled-Filhart, Marisa, PhD, Garon, Edward B, MD

Volltext

Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer von Hwang, Sohyun, Kwon, Ah-Young, Jeong, Ju-Yeon, Kim, Sewha, Kang, Haeyoun, Park, Joonsuk, Kim, Joo-Hang, Han, Ok Jin, Lim, Sun Min, An, Hee Jung

Volltext

Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component von Yang, James Chih-Hsin, Ahn, Myung-Ju, Kim, Dong-Wan, Ramalingam, Suresh S, Sequist, Lecia V, Su, Wu-Chou, Kim, Sang-We, Kim, Joo-Hang, Planchard, David, Felip, Enriqueta, Blackhall, Fiona, Haggstrom, Daniel, Yoh, Kiyotaka, Novello, Silvia, Gold, Kathryn, Hirashima, Tomonori, Lin, Chia-Chi, Mann, Helen, Cantarini, Mireille, Ghiorghiu, Serban, Jänne, Pasi A

Volltext

Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, m... von Ahn, Myung-Ju, Han, Ji-Youn, Lee, Ki Hyeong, Kim, Sang-We, Kim, Dong-Wan, Lee, Yun-Gyoo, Cho, Eun Kyung, Kim, Joo-Hang, Lee, Gyeong-Won, Lee, Jong-Seok, Min, Young Joo, Kim, Jin-Soo, Lee, Sung Sook, Kim, Hye Ryun, Hong, Min Hee, Ahn, Jin Seok, Sun, Jong-Mu, Kim, Heung Tae, Lee, Dae Ho, Kim, Sohee, Cho, Byoung Chul

Volltext

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL... von Garon, Edward B, Dr, Ciuleanu, Tudor-Eliade, Prof, Arrieta, Oscar, MD, Prabhash, Kumar, Prof, Syrigos, Konstantinos N, Prof, Goksel, Tuncay, Prof, Park, Keunchil, Prof, Gorbunova, Vera, MD, Kowalyszyn, Ruben Dario, MD, Pikiel, Joanna, MD, Czyzewicz, Grzegorz, MD, Orlov, Sergey V, Prof, Lewanski, Conrad R, MD, Thomas, Michael, Prof, Bidoli, Paolo, MD, Dakhil, Shaker, MD, Gans, Steven, MD, Kim, Joo-Hang, Prof, Grigorescu, Alexandru, Prof, Karaseva, Nina, MD, Reck, Martin, MD, Cappuzzo, Federico, MD, Alexandris, Ekaterine, MS, Sashegyi, Andreas, PhD, Yurasov, Sergey, MD, Pérol, Maurice, MD

Volltext

Randomized Phase III Trial of Maintenance Bevacizumab With or Without Pemetrexed After First-Line Induction With Bevacizumab, Cisplatin, and Pemetrexed in Advanced Nonsquamous Non–... von BARLESI, Fabrice, SCHERPEREEL, Arnaud, WONG, Elaine K, PEREZ-MORENO, Pablo, MITCHELL, Lada, GROEN, Harry J. M, RITTMEYER, Achim, PAZZOLA, Antonio, FERRER TUR, Neus, KIM, Joo-Hang, AHN, Myung-Ju, AERTS, Joachim G. J. V, GORBUNOVA, Vera, VIKSTRÖM, Anders

Volltext

Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer von Cho, Arthur, Hur, Jin, Moon, Yong Wha, Hong, Sae Rom, Suh, Young Joo, Kim, Yun Jung, Im, Dong Jin, Hong, Yoo Jin, Lee, Hye-Jeong, Kim, Young Jin, Shim, Hyo Sup, Lee, Jae Seok, Kim, Joo-Hang, Choi, Byoung Wook

Volltext

Antitumor effects of IL-12 and GM-CSF co-expressed in an engineered oncolytic HSV-1 von Kim, Kyoung-Ju, Moon, Dahye, Kong, So Jung, Lee, Yu Seong, Yoo, Youngeun, Kim, Soyoung, Kim, Chan, Chon, Hong Jae, Kim, Joo-Hang, Choi, Kyung-Ju

Volltext

The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib von Vishwanathan, Karthick, Dickinson, Paul A., So, Karen, Thomas, Karen, Chen, Yuh‐Min, De Castro Carpeño, Javier, Dingemans, Anne‐Marie C., Kim, Hye Ryun, Kim, Joo‐Hang, Krebs, Matthew G., Chih‐Hsin Yang, James, Bui, Khanh, Weilert, Doris, Harvey, R. Donald

Volltext

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study von Ciuleanu, Tudor, MD, Brodowicz, Thomas, MD, Zielinski, Christoph, Prof, Kim, Joo Hang, MD, Krzakowski, Maciej, Prof, Laack, Eckart, MD, Wu, Yi-Long, Prof, Bover, Isabel, MD, Begbie, Stephen, MD, Tzekova, Valentina, MD, Cucevic, Branka, MD, Pereira, Jose Rodrigues, MD, Yang, Sung Hyun, MD, Madhavan, Jayaprakash, MD, Sugarman, Katherine P, MD, Peterson, Patrick, PhD, John, William J, MD, Krejcy, Kurt, MD, Belani, Chandra P, Dr

Volltext

An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naive patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mut... von Park, Keunchil, Kim, Jin-Soo, Kim, Joo-Hang, Kim, Young-Chul, Kim, Hoon-Gu, Cho, Eun Kyung, Jin, Jong-Youl, Kim, Miyoung, Marten, Angela, Kang, Jin-Hyoung

Volltext

Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma von Kim, Ahreum, Lim, Sun Min, Kim, Joo-Hang, Seo, Jeong-Sun

Volltext

A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer von Kang, Jin-Hyoung, Lee, Ki-Hyeong, Kim, Dong-Wan, Kim, Sang-We, Kim, Hye Ryun, Kim, Joo-Hang, Choi, Jin-Hyuk, An, Ho Jung, Kim, Jin-Soo, Jang, Joung-Soon, Kim, Bong-Seog, Kim, Heung Tae

Volltext

The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges von Sang, Yun Beom, Kim, Joo-Hang, Kim, Chang-Gon, Hong, Min Hee, Kim, Hye Ryun, Cho, Byoung Chul, Lim, Sun Min

Volltext

Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study von Han, Ji-Youn, Ahn, Myung-Ju, Lee, Ki Hyeong, Lee, Yun-Gyoo, Kim, Dong-Wan, Min, Young Joo, Kim, Sang-We, Cho, Eun Kyung, Kim, Joo-Hang, Lee, Gyeong-Won, Lee, Sung Sook, Lee, Na Mi, Jang, Hyun Woo, Han, Heewon, Park, Hyejoo, Lee, Jieon, Cho, Byoung Chul

Volltext

Real‐world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study von Lee, Jiyun, Ahn, Hee Kyung, Kim, Sang‐We, Han, Ji‐Youn, Lee, Sung Sook, Park, Hyung Soon, Lee, Hyun Woo, Kim, Joo‐Hang, Cho, Eunhan, Huggenberger, Reto, Cho, Byoung Chul

Volltext

Lazertinib as a frontline treatment in patients with EGFR-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201 von Chul Cho, Byoung, Han, Ji-Youn, Hyeong Lee, Ki, Lee, Yun-Gyoo, Kim, Dong-Wan, Joo Min, Young, Kim, Sang-We, Kyung Cho, Eun, Kim, Joo-Hang, Lee, Gyeong-Won, Sook Lee, Sung, Lee, NaMi, Young Wang, Jang, Park, Hyejoo, Ahn, Myung-Ju

Volltext

Relaxin Expression From Tumor-Targeting Adenoviruses and Its Intratumoral Spread, Apoptosis Induction, and Efficacy von Kim, Joo-Hang, Lee, Young-Sook, Kim, Hoguen, Huang, Jing-Hua, Yoon, A-Rum, Yun, Chae-Ok

Volltext

Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution von Park, Hyung Soon, Lim, Sun Min, Kim, Sora, Kim, Sangwoo, Kim, Hye Ryun, Kwack, KyuBum, Lee, Min Goo, Kim, Joo-Hang, Moon, Yong Wha

Volltext